PMID- 28445668
OWN - NLM
STAT- MEDLINE
DCOM- 20171026
LR  - 20171026
IS  - 1533-4406 (Electronic)
IS  - 0028-4793 (Linking)
VI  - 376
IP  - 17
DP  - 2017 Apr 27
TI  - Adalimumab in the Treatment of Uveitis in Juvenile Idiopathic Arthritis.
PG  - 1682-1683
LID - 10.1056/NEJMe1701811 [doi]
FAU - Thorne, Jennifer E
AU  - Thorne JE
AD  - From the Wilmer Eye Institute, Johns Hopkins University School of Medicine, and
      the Department of Epidemiology, Johns Hopkins University Bloomberg School of
      Public Health - both in Baltimore.
LA  - eng
PT  - Editorial
PL  - United States
TA  - N Engl J Med
JT  - The New England journal of medicine
JID - 0255562
RN  - 0 (Antirheumatic Agents)
RN  - FYS6T7F842 (Adalimumab)
SB  - AIM
SB  - IM
MH  - *Adalimumab
MH  - Antirheumatic Agents
MH  - *Arthritis, Juvenile
MH  - Humans
MH  - Uveitis
EDAT- 2017/04/27 06:00
MHDA- 2017/10/27 06:00
CRDT- 2017/04/27 06:00
PHST- 2017/04/27 06:00 [entrez]
PHST- 2017/04/27 06:00 [pubmed]
PHST- 2017/10/27 06:00 [medline]
AID - 10.1056/NEJMe1701811 [doi]
PST - ppublish
SO  - N Engl J Med. 2017 Apr 27;376(17):1682-1683. doi: 10.1056/NEJMe1701811.